CSP
5 min read
133

Biosergen Completes First Cohort of BSG005 Clinical Trial, Shows Promising Potential in Drug-Resistant Fungal Infections

October 31, 2024
0

Reading Time: 4 minutes October 31, 2024 – Biosergen AB (“Biosergen”), a clinical-stage biotechnology company developing therapies for life-threatening fungal diseases, today announced the completion of treatment for the first cohort of patients in its proof-of-concept clinical trial for its antifungal drug-candidate BSG005. The cohort

Continue Reading
CSP
3 min read
47

Rule, Build, and Thrive in Tlatoani: Aztec Cities—Out Now in Steam Early Access

October 31, 2024
0

Reading Time: 2 minutes STOCKHOLM, October 31st, 2024 – Today, Paradox Arc, Perspective Games, and Bellwood Studios released their city-building game, Tlatoani: Aztec Cities, into Steam Early Access. The game features a deep simulation of an Aztec city-state along with beautiful hand-drawn 2D graphics that

Continue Reading
CSP
1 min read
47

Fortum Corporation: Managers’ transactions – Mikael Lemström

October 31, 2024
0

Reading Time: < 1 minute FORTUM CORPORATION STOCK EXCHANGE RELEASE 31 OCTOBER 2024 AT 17:30 EET Release category: Managers’ transactions Person subject to the notification requirement Name: Lemström, Mikael Position: Other senior manager Issuer: Fortum Corporation LEI: 635400IUIZZIUJSAMF76 Notification type: INITIAL NOTIFICATION Reference number: 635400IUIZZIUJSAMF76_20241031130721_298

Continue Reading
CSP
1 min read
42

Change in Wetteri Plc’s Management Team

October 31, 2024
0

Reading Time: < 1 minute Wetteri Plc  Stock Exchange Release 31 October 2024 at 16.30 Sanna Räsänen, member of the management team of Wetteri Plc, HR and Communications Director, has resigned from her position. Räsänen will continue to work for Wetteri until 30th November 2024,

Continue Reading
CSP
3 min read
33

Diagonal announces first pilot test at a stud with LAMPlify®

October 31, 2024
0

Reading Time: 2 minutes Read original Diagonal Bio AB (publ) (“Diagonal Bio” or “the Company”) announces a partnership with Gocksta Stud (Gocksta Stuteri), led by Anne-Sophie Thiam, to conduct a three-month pilot study, which begins immediately. This pilot test will evaluate LAMPlify’s potential for rapid detection

Continue Reading
Paige Spiranac Expands SportsGrid’s Content Portfolio with Exclusive Sports and Casino-Themed Shows
CSP
2 min read
37

Paige Spiranac Expands SportsGrid’s Content Portfolio with Exclusive Sports and Casino-Themed Shows

October 31, 2024
0

Reading Time: 2 minutes SportsGrid, the leading free ad supported television network in the sports genre, proudly announces a multi-year partnership with former professional golfer and social media’s most followed golf personality and social media sensation Paige Spiranac. Under this agreement, Spiranac will lead exclusive

Continue Reading
CSP
6 min read
43

Casino Etiquette: 75% of Players Make Mistakes on Their First Visit

October 31, 2024
0

Reading Time: 4 minutes Did you know? 78% of first-time visitors to a casino are unaware of the tipping culture. 60% of new players don’t realise that using their phones at the table is prohibited. 35% of newcomers have been asked to leave a game for

Continue Reading
Spinomenal Celebrates Halloween with Book of the Cursed Release
CSP
2 min read
45

Spinomenal Celebrates Halloween with Book of the Cursed Release

October 31, 2024
0

Reading Time: 2 minutes Leading iGaming content provider Spinomenal is celebrating Halloween with the release of its spine-tingling slot, Book of the Cursed. An eerie soundtrack ensures players will feel goosebumps on the reels which sits within a 5×3 framework. Set within a macabre

Continue Reading
CSP
11 min read
55

Lundbeck announces positive results from phase III pivotal trial (SUNRISE) of Vyepti® (eptinezumab) in migraine prevention

October 31, 2024
0

Reading Time: 8 minutes Vyepti® confirms efficacy in new phase III pivotal SUNRISE trial, meeting primary endpoint with statistically significant reductions in mean monthly migraine days compared with placebo Vyepti® met all key secondary efficacy endpoints in the SUNRISE trial, and the treatment was generally

Continue Reading
CSP
1 min read
36

CORRECTION: Aker Solutions ASA: Third-Quarter Results 2024

October 31, 2024
0

Reading Time: < 1 minute October 31, 2024 – Aker Solutions today published its third-quarter results for 2024.  Correction: A revised version of the presentation is enclosed, addressing an error on slide 15 of the original presentation released at 07:00 CET.  The previous slide incorrectly

Continue Reading